Anthony H Nguyen

Array ( [id] => 1357512 [patent_doc_number] => 06573072 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Ribozymes having 2-O substituted nucleotides in the flanking sequences' [patent_app_type] => B1 [patent_app_number] => 09/687427 [patent_app_country] => US [patent_app_date] => 2000-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 4676 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573072.pdf [firstpage_image] =>[orig_patent_app_number] => 09687427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1099213 [patent_doc_number] => 06818447 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-16 [patent_title] => 'Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor' [patent_app_type] => B1 [patent_app_number] => 09/685664 [patent_app_country] => US [patent_app_date] => 2000-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 23 [patent_no_of_words] => 55999 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/818/06818447.pdf [firstpage_image] =>[orig_patent_app_number] => 09685664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 766054 [patent_doc_number] => 07008791 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-03-07 [patent_title] => 'Liposome-entrapped DNA oral vaccines' [patent_app_type] => utility [patent_app_number] => 10/089312 [patent_app_country] => US [patent_app_date] => 2000-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 18 [patent_no_of_words] => 4632 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 245 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/008/07008791.pdf [firstpage_image] =>[orig_patent_app_number] => 10089312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1248740 [patent_doc_number] => 06673917 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-06 [patent_title] => 'Antisense IAP nucleic acids and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/672717 [patent_app_country] => US [patent_app_date] => 2000-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 33 [patent_no_of_words] => 26673 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673917.pdf [firstpage_image] =>[orig_patent_app_number] => 09672717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1516924 [patent_doc_number] => 06500619 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Method for making an improved cloning vector containing marker inactivation system' [patent_app_type] => B1 [patent_app_number] => 09/665494 [patent_app_country] => US [patent_app_date] => 2000-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 11266 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 217 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500619.pdf [firstpage_image] =>[orig_patent_app_number] => 09665494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1365235 [patent_doc_number] => 06569979 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-27 [patent_title] => 'Modified carbon, silicon, & germanium surfaces' [patent_app_type] => B1 [patent_app_number] => 09/659442 [patent_app_country] => US [patent_app_date] => 2000-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 8203 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/569/06569979.pdf [firstpage_image] =>[orig_patent_app_number] => 09659442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1345265 [patent_doc_number] => 06582932 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-24 [patent_title] => 'Calpain and DNA encoding the same' [patent_app_type] => B1 [patent_app_number] => 09/622880 [patent_app_country] => US [patent_app_date] => 2000-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14272 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/582/06582932.pdf [firstpage_image] =>[orig_patent_app_number] => 09622880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1108368 [patent_doc_number] => 06809195 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-26 [patent_title] => 'Process for the preparation of oligonucleotides' [patent_app_type] => B1 [patent_app_number] => 09/640279 [patent_app_country] => US [patent_app_date] => 2000-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15251 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 469 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/809/06809195.pdf [firstpage_image] =>[orig_patent_app_number] => 09640279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1577835 [patent_doc_number] => 06448079 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Antisense modulation of p38 mitogen activated protein kinase expression' [patent_app_type] => B1 [patent_app_number] => 09/640101 [patent_app_country] => US [patent_app_date] => 2000-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25106 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448079.pdf [firstpage_image] =>[orig_patent_app_number] => 09640101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1484719 [patent_doc_number] => 06365354 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Antisense modulation of lysophospholipase I expression' [patent_app_type] => B1 [patent_app_number] => 09/629645 [patent_app_country] => US [patent_app_date] => 2000-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28666 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365354.pdf [firstpage_image] =>[orig_patent_app_number] => 09629645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1391610 [patent_doc_number] => 06541222 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Plant promoter isolated from Douglas-fir 2S seed storage protein gene' [patent_app_type] => B1 [patent_app_number] => 09/627536 [patent_app_country] => US [patent_app_date] => 2000-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10902 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541222.pdf [firstpage_image] =>[orig_patent_app_number] => 09627536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1403680 [patent_doc_number] => 06528054 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'Compositions and methods for the therapy and diagnosis of breast cancer' [patent_app_type] => B1 [patent_app_number] => 09/620405 [patent_app_country] => US [patent_app_date] => 2000-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 86767 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528054.pdf [firstpage_image] =>[orig_patent_app_number] => 09620405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4411784 [patent_doc_number] => 06300492 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Modulation of IAPs for the diagnosis and antisense treatment of proliferative disease' [patent_app_type] => 1 [patent_app_number] => 9/617053 [patent_app_country] => US [patent_app_date] => 2000-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 31 [patent_no_of_words] => 26517 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300492.pdf [firstpage_image] =>[orig_patent_app_number] => 617053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 751124 [patent_doc_number] => 07022892 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-04-04 [patent_title] => 'Non-human genetically modified mammal lacking the alpha-fetoprotein' [patent_app_type] => utility [patent_app_number] => 10/031021 [patent_app_country] => US [patent_app_date] => 2000-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3800 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022892.pdf [firstpage_image] =>[orig_patent_app_number] => 10031021 [rel_patent_id] =>[rel_patent_doc_number] =>)